Build Your Comparison

Side-by-side financial analysis
CLB logo
CLB
XOM logo
XOM
JPM logo
JPM
KO logo
KO
CVX logo
CVX
Try popular comparisons:

Stock Comparison

CLB vs XOM vs JPM vs KO vs CVX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CLB
Core Laboratories N.V.

Oil & Gas Equipment & Services

EnergyNYSE • NL
Market Cap$586M
5Y Perf.-37.4%
XOM
Exxon Mobil Corporation

Oil & Gas Integrated

EnergyNYSE • US
Market Cap$597.52B
5Y Perf.+215.3%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$892.31B
5Y Perf.+239.6%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$348.25B
5Y Perf.+81.1%
CVX
Chevron Corporation

Oil & Gas Integrated

EnergyNYSE • US
Market Cap$359.97B
5Y Perf.+102.2%

CLB vs XOM vs JPM vs KO vs CVX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CLB logoCLB
XOM logoXOM
JPM logoJPM
KO logoKO
CVX logoCVX
IndustryOil & Gas Equipment & ServicesOil & Gas IntegratedBanks - DiversifiedBeverages - Non-AlcoholicOil & Gas Integrated
Market Cap$586M$597.52B$892.31B$348.25B$359.97B
Revenue (TTM)$525M$323.90B$280.33B$49.28B$184.43B
Net Income (TTM)$31M$28.84B$57.05B$13.70B$12.30B
Gross Margin17.8%21.7%60.0%61.7%30.4%
Operating Margin10.0%10.5%25.9%29.3%9.0%
Forward P/E21.2x12.9x14.3x24.7x12.6x
Total Debt$206M$43.54B$942.38B$45.49B$46.74B
Cash & Equiv.$23M$10.68B$343.34B$10.27B$6.47B

CLB vs XOM vs JPM vs KO vs CVXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CLB
XOM
JPM
KO
CVX
StockJun 20Jun 26Return
Core Laboratories N… (CLB)10062.6-37.4%
Exxon Mobil Corpora… (XOM)100315.3+215.3%
JPMorgan Chase & Co. (JPM)100339.6+239.6%
The Coca-Cola Compa… (KO)100181.1+81.1%
Chevron Corporation (CVX)100202.2+102.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: CLB vs XOM vs JPM vs KO vs CVX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. The Coca-Cola Company is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. XOM and CVX also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
CLB
Core Laboratories N.V.
The Defensive Pick

CLB is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.96, Low D/E 73.8%, current ratio 2.07x
  • Beta 0.96, yield 0.3%, current ratio 2.07x
Best for: sleep-well-at-night and defensive
XOM
Exxon Mobil Corporation
The Momentum Pick

XOM ranks third and is worth considering specifically for momentum.

  • +29.0% vs CLB's +5.3%
Best for: momentum
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 475.6% 10Y total return vs CVX's 133.7%
  • PEG 0.81 vs KO's 2.21
  • 3.3% NII/revenue growth vs CVX's -4.6%
Best for: income & stability and long-term compounding
KO
The Coca-Cola Company
The Growth Play

KO is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 1.9%, EPS growth 23.6%, 3Y rev CAGR 3.7%
  • 27.8% margin vs CLB's 5.9%
  • 13.1% ROA vs JPM's 1.3%, ROIC 15.8% vs 4.5%
Best for: growth exposure
CVX
Chevron Corporation
The Income Pick

CVX is the clearest fit if your priority is dividends.

  • 3.8% yield, 38-year raise streak, vs KO's 2.5%
Best for: dividends
See the full category breakdown
CategoryWinnerWhy
GrowthJPM logoJPM3.3% NII/revenue growth vs CVX's -4.6%
ValueJPM logoJPMLower P/E (14.3x vs 24.7x), PEG 0.81 vs 2.21
Quality / MarginsKO logoKO27.8% margin vs CLB's 5.9%
Stability / SafetyJPM logoJPMBeta 0.94 vs CLB's 0.96
DividendsCVX logoCVX3.8% yield, 38-year raise streak, vs KO's 2.5%
Momentum (1Y)XOM logoXOM+29.0% vs CLB's +5.3%
Efficiency (ROA)KO logoKO13.1% ROA vs JPM's 1.3%, ROIC 15.8% vs 4.5%

CLB vs XOM vs JPM vs KO vs CVX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Oil & Gas Stocks Theme

These companies are key players in the Oil & Gas Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
CLBCore Laboratories N.V.
FY 2025
Service
75.9%$399M
Product
24.1%$127M
XOMExxon Mobil Corporation
FY 2025
Energy Products
68.7%$217.8B
Upstream
17.6%$55.7B
Chemical Products
6.0%$18.9B
Specialty Products
5.4%$17.3B
Income From Equity Affiliates
1.7%$5.3B
Other Revenue
0.6%$2.1B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B
CVXChevron Corporation
FY 2025
Downstream
61.1%$72.5B
Upstream
38.4%$45.5B
All Other Segments
0.5%$644M

CLB vs XOM vs JPM vs KO vs CVX — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGCVX

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 5 of 6 comparable metrics.

XOM is the larger business by revenue, generating $323.9B annually — 617.3x CLB's $525M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to CLB's 5.9%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCLB logoCLBCore Laboratories…XOM logoXOMExxon Mobil Corpo…JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CVX logoCVXChevron Corporati…
RevenueTrailing 12 months$525M$323.9B$280.3B$49.3B$184.4B
EBITDAEarnings before interest/tax$71M$59.9B$81.4B$15.5B$37.1B
Net IncomeAfter-tax profit$31M$28.8B$57.0B$13.7B$12.3B
Free Cash FlowCash after capex$24M$23.6B$100.9B$12.6B$16.2B
Gross MarginGross profit ÷ Revenue+17.8%+21.7%+60.0%+61.7%+30.4%
Operating MarginEBIT ÷ Revenue+10.0%+10.5%+25.9%+29.3%+9.0%
Net MarginNet income ÷ Revenue+5.9%+8.9%+20.4%+27.8%+6.7%
FCF MarginFCF ÷ Revenue+4.5%+7.3%+36.0%+25.5%+8.8%
Rev. Growth (YoY)Latest quarter vs prior year-1.4%-1.3%+12.1%-5.3%
EPS Growth (YoY)Latest quarter vs prior year-11.0%+16.0%+18.2%-24.5%
KO leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

JPM leads this category, winning 3 of 7 comparable metrics.

At 15.9x trailing earnings, JPM trades at a 41% valuation discount to CVX's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs KO's 2.38x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCLB logoCLBCore Laboratories…XOM logoXOMExxon Mobil Corpo…JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CVX logoCVXChevron Corporati…
Market CapShares × price$586M$597.5B$892.3B$348.2B$360.0B
Enterprise ValueMkt cap + debt − cash$769M$630.4B$1.49T$383.5B$400.2B
Trailing P/EPrice ÷ TTM EPS18.71x21.04x15.93x26.62x27.21x
Forward P/EPrice ÷ next-FY EPS est.21.24x12.86x14.34x24.75x12.61x
PEG RatioP/E ÷ EPS growth rate0.90x2.38x
EV / EBITDAEnterprise value multiple12.11x10.52x18.32x25.89x10.78x
Price / SalesMarket cap ÷ Revenue1.11x1.84x3.19x7.26x1.95x
Price / BookPrice ÷ Book value/share2.11x2.28x2.46x10.18x1.74x
Price / FCFMarket cap ÷ FCF25.93x25.31x8.85x65.76x21.70x
JPM leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 5 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $7 for CVX. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs XOM's 3/9, reflecting strong financial health.

MetricCLB logoCLBCore Laboratories…XOM logoXOMExxon Mobil Corpo…JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CVX logoCVXChevron Corporati…
ROE (TTM)Return on equity+11.3%+10.7%+15.9%+41.1%+7.2%
ROA (TTM)Return on assets+5.2%+6.4%+1.3%+13.1%+4.2%
ROICReturn on invested capital+8.3%+8.6%+4.5%+15.8%+6.2%
ROCEReturn on capital employed+9.9%+8.9%+8.9%+17.3%+6.6%
Piotroski ScoreFundamental quality 0–963575
Debt / EquityFinancial leverage0.74x0.16x2.60x1.33x0.24x
Net DebtTotal debt minus cash$183M$32.9B$599.0B$35.2B$40.3B
Cash & Equiv.Liquid assets$23M$10.7B$343.3B$10.3B$6.5B
Total DebtShort + long-term debt$206M$43.5B$942.4B$45.5B$46.7B
Interest CoverageEBIT ÷ Interest expense5.18x69.44x0.74x10.70x17.22x
KO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in XOM five years ago would be worth $24,852 today (with dividends reinvested), compared to $2,851 for CLB. Over the past 12 months, XOM leads with a +29.0% total return vs CLB's +5.3%. The 3-year compound annual growth rate (CAGR) favors JPM at 32.7% vs CLB's -17.0% — a key indicator of consistent wealth creation.

MetricCLB logoCLBCore Laboratories…XOM logoXOMExxon Mobil Corpo…JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CVX logoCVXChevron Corporati…
YTD ReturnYear-to-date-24.8%+16.6%-0.9%+18.6%+18.0%
1-Year ReturnPast 12 months+5.3%+29.0%+20.3%+17.7%+28.3%
3-Year ReturnCumulative with dividends-42.8%+44.3%+133.8%+42.6%+26.6%
5-Year ReturnCumulative with dividends-71.5%+148.5%+120.7%+63.1%+91.9%
10-Year ReturnCumulative with dividends-83.0%+95.6%+475.6%+118.2%+133.7%
CAGR (3Y)Annualised 3-year return-17.0%+13.0%+32.7%+12.6%+8.2%
JPM leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — XOM and KO each lead in 1 of 2 comparable metrics.

XOM is the less volatile stock with a -0.37 beta — it tends to amplify market swings less than CLB's 0.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 96.3% from its 52-week high vs CLB's 62.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCLB logoCLBCore Laboratories…XOM logoXOMExxon Mobil Corpo…JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CVX logoCVXChevron Corporati…
Beta (5Y)Sensitivity to S&P 5000.96x-0.37x0.94x-0.20x-0.31x
52-Week HighHighest price in past year$20.36$176.41$337.25$84.04$214.71
52-Week LowLowest price in past year$9.72$105.53$266.85$65.35$142.40
% of 52W HighCurrent price vs 52-week peak+62.5%+79.9%+94.7%+96.3%+84.0%
RSI (14)Momentum oscillator 0–10041.243.365.060.848.7
Avg Volume (50D)Average daily shares traded445K13.7M7.0M12.7M8.1M
Evenly matched — XOM and KO each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KO and CVX each lead in 1 of 2 comparable metrics.

Analyst consensus: CLB as "Hold", XOM as "Hold", JPM as "Buy", KO as "Buy", CVX as "Buy". Consensus price targets imply 96.5% upside for CLB (target: $25) vs 6.4% for JPM (target: $340). For income investors, CVX offers the higher dividend yield at 3.81% vs CLB's 0.32%.

MetricCLB logoCLBCore Laboratories…XOM logoXOMExxon Mobil Corpo…JPM logoJPMJPMorgan Chase & …KO logoKOThe Coca-Cola Com…CVX logoCVXChevron Corporati…
Analyst RatingConsensus buy/hold/sellHoldHoldBuyBuyBuy
Price TargetConsensus 12-month target$25.00$170.08$339.75$86.13$200.13
# AnalystsCovering analysts3755614853
Dividend YieldAnnual dividend ÷ price+0.3%+2.8%+1.9%+2.5%+3.8%
Dividend StreakConsecutive years of raises043155638
Dividend / ShareAnnual DPS$0.04$4.00$5.95$2.04$6.87
Buyback YieldShare repurchases ÷ mkt cap+2.1%+3.4%+3.9%+0.2%+3.3%
Evenly matched — KO and CVX each lead in 1 of 2 comparable metrics.
Key Takeaway

KO leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JPM leads in 2 (Valuation Metrics, Total Returns). 2 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

CLB vs XOM vs JPM vs KO vs CVX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CLB or XOM or JPM or KO or CVX a better buy right now?

For growth investors, JPMorgan Chase & Co.

(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 9x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CLB or XOM or JPM or KO or CVX?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 15. 9x versus Chevron Corporation at 27. 2x. On forward P/E, Chevron Corporation is actually cheaper at 12. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus The Coca-Cola Company's 2. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — CLB or XOM or JPM or KO or CVX?

Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +148.

5%, compared to -71. 5% for Core Laboratories N. V. (CLB). Over 10 years, the gap is even starker: JPM returned +475. 6% versus CLB's -83. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CLB or XOM or JPM or KO or CVX?

By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.

37β versus Core Laboratories N. V. 's 0. 96β — meaning CLB is approximately -357% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CLB or XOM or JPM or KO or CVX?

By revenue growth (latest reported year), JPMorgan Chase & Co.

(JPM) is pulling ahead at 3. 3% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CLB or XOM or JPM or KO or CVX?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus 6. 0% for Core Laboratories N. V. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 9. 0% for CVX. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CLB or XOM or JPM or KO or CVX more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus The Coca-Cola Company's 2. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Chevron Corporation (CVX) trades at 12. 6x forward P/E versus 24. 7x for The Coca-Cola Company — 12. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLB: 96. 5% to $25. 00.

08

Which pays a better dividend — CLB or XOM or JPM or KO or CVX?

All stocks in this comparison pay dividends.

Chevron Corporation (CVX) offers the highest yield at 3. 8%, versus 0. 3% for Core Laboratories N. V. (CLB).

09

Is CLB or XOM or JPM or KO or CVX better for a retirement portfolio?

For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

37), 2. 8% yield). Both have compounded well over 10 years (XOM: +95. 6%, CLB: -83. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CLB and XOM and JPM and KO and CVX?

These companies operate in different sectors (CLB (Energy) and XOM (Energy) and JPM (Financial Services) and KO (Consumer Defensive) and CVX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CLB is a small-cap quality compounder stock; XOM is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock. XOM, JPM, KO, CVX pay a dividend while CLB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.